CN

THE SYNBIO & GENE CELL THERAPY INDUSTRIAL CHAIN FORUM 2021 BACK TO STAGE!

Unfolded on December 1-2. We are very psyched to announce that our annual Synthetic Biology and Gene Cell Therapy activities will now officially be open for registration!

At this year's event, we practically are gathering thought leaders, decision-makers, C-Suite executives, investors, academic researchers, entrepreneurs, and practitioners around from all corners of the globe in the synthetic biology community and advanced gene cell therapy society to share their insights and visions not only in the academic setting but industry trend updates.

Encapsulating this excitement, SynBio & GCT Summit will broadly dive into what's-on-the-horizon topics in science, emerging technologies, applications, and investment from top to bottom. On top of that, gene cell therapy vertically being a precise application in the realm of synthetic biology will largely be learned and discussed including mRNA therapy especially in this unprecedented times, on-hands in-vivo and ex-vivo gene editing, our first-ever CART product approved, gene therapeutics, immune therapies, bioprocessing & CMC, commercialization, and global competitive landscape and beyond over our two-day exciting program agenda.

Set your calendar at the 4th SynBio & Gene Cell Therapy Industrial Chain Forum today!

MEET OUR FEATURED SPEAKERS

*Name in Alphabetical order

Runsheng Chen

Member of the Chinese Academy of Sciences,
Director of Academic Board, Chinese Academy of Sciences Key Laboratory of Nucleic Acid Biology, Institute of Biophysics

Zixin Deng

Fellow of American Academy of Microbiology, Head of the State Key Laboratory of Microbial Metabolism in China, President of Chinese Society for Microbiology

Gaojun Teng

Member of the Chinese Academy of Sciences, Chief Physician, Chief Professor and Doctoral Supervisor ,Southeast University

Zhigang Tian

Member of the Chinese Academy of Engineering Director of Institute of Immunology, Dean of the school of Basic Medicine (USTC)

Huanming Yang

Ph.D., Prof., Member of Chinese Academy of Sciences,
Professor at the University of Chinese Academy of Sciences and the Chinese Academy of Medical Sciences,
Vice-President of the Genetics Society of China and the Chinese Society for Urban Science Research, Chairman and Co-founder of BGI

Yingjin Yuan

Member of the Chinese Academy of Sciences,
Professor at Tianjin University (Virtual)

Guoping Zhao

Member of the Chinese Academy of Sciences, Molecular Microbiologist, Principal Investigator at CAS Center for Excellence in Molecular Plant Sciences, Head of Department of Microbiology and Immunology at School of Life Sciences Fudan University

Linfa Wang

Member of Australian Academy of Technology and Engineering
Professor, Program in Emerging Infectious Diseases, DukeNUS Medical School, Singapore
Executive Director, PREPARE (Programme for Research in Epidemic Preparedness and Responses), Singapore

Brian Min

CEO
GenScript ProBio

Ling Chen

Standing Deputy Director General at State Key Laboratory of Respiratory Diseases
Principal Investigator at Guangzhou Institutes of Biomedicine and Health, CAS

Zengjiang Cheng

Founder of Tongxieyi Forum; Secretary General of Tongxieyi New Drug Elite Club; Chairman, PharmaSea

Frank Fan

Chief Scientific Officer
Legend Biotech Corporation

Yongjun Fang

Chief physician of Hematology Oncology Department ,
Nanjing Children's Hospital

Haotian Guo

Co-founder/CEO
Ailurus Biotechnology

Xinqi Gong

Professor at Institute for Mathematical Sciences
Renmin Unversity of China

Winnie Han

Senior Vice President
Global Issuer Services HKEX

Hong He

Co-founder/CEO
Xiamen Chokhmah Biotech

Aimin Hui

Executive President, President of Global R&D & Chief Medical Officer, Fosun Pharma

Weiming Jiang

Former President, DSM China

Hangwen Li

Founder/CEO
Stemirna Therapeutics Co., Ltd.

Hong Li

VP of Global R&D Center, GenScript Biotech Corporation

James Li

Co-founder/Chairman/CEO
JW Therapeutics

Kechun Li

Partner, YuanBio Venture Capital

Yi Li

Principal Investigator at Bioland Laboratory, Principal Investigator at Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences

Joshua Ling

Chairman, Sino Boundary Medical Innovation Fund

Sean Liour

Head of PM & RA, GenScript ProBio

Xiucai Liu

Founder/Chairman/CEO
, Cathay Biotech

Dong Lyu

Managing Director
Zhuhai Gao Ling Equity Investment Management Co., Ltd.

Lijia Ma

Professor, Distinguished Principal Investigator at School of Life Sciences, Westlake University

Li Mao

CMO
Sino Biopharmaceutical Limited

Feifei Qi

Co-founder/CTO
Immunochina Pharmaceuticals

Cheng Qian

Chief Scientist ,Chongqing Precision Biotech

Hong Qian

Chief Operating Officer of GenScript Life Sciences Group GenScript Biotech Corporation

Alvin Syh

CEO of ANRICH CAPITAL
CEO of BC Asset Management Centre

Xiaodi Su

Vice President
Lilly Asia Ventures

Tao Wan

Professor of National Key Laboratory of Medical Immunology

Bin Wang

Founder & Chairman at Science Committee,
Advaccine Biotech

Bin Wang

Vice President
GL Ventures

John Wang

Executive Partner, GTJA Investment Group

§ Junfeng Wang

Managing Director, Legend Capital

Richard Wang

Founder/Chairman/CEO
Neukio Biotherapeutics

Xiaoning Wang

General Secretary of China Union of Life Science Societies

Yaning Wang

CEO
Createrna Science & Technology
Former Director of the Division of Pharmacometrics, FDA Clinical Pharmacology

Zhenhua Wu

Founder/CEO
Exegenesis Bio

Darren Xiao, Managing Director

Co-Head of Pharmaceutical Team
SDIC Fund Management Co., Ltd.

Julia Xing

Founder/CEO
Shi Hua Medicine Co., Ltd./XPrecision LLC

Zhen Xie

Adjunct Professor at Center for Synthetic & Systems Biology/CSO
Tsinghua University/SyngenTech

Lin Yang

Founder/Chairman
PersonGen BioTherapeutics

Haifeng Ye

Professor at School of Life Sciences
East China Normal University

Chenyu Zhang

Professor and Dean of the School of Life Sciences
Nanjing University

Dan Zhang

Co-Founder & Chief Strategy Officer, ClinChoice; Foreign Member of Russian Academy of Engineering

Haoqian Zhang

Co-founder/CEO
Bluepha

Xiao Zhang

Partner, Leader of Pharma & Biotech Team,CEC Capital

Yi Zhang

Professor/Director in Biotherapy Center &
Cancer Center, First Affiliated Hospital of Zhengzhou University

Yu Zhang

The SVP&CSO of Vcanbio Cell&Gene Engineering Corp.,Ltd

Adam Zhao

Founder of the AnlongMed/AnlongBio

Ben Zhao Ph.D.

Zhejiang Haichang Biotech Co., Ltd Founder

Rudy Zhou

General Manager, Bestzyme Bio-engineering Co., Ltd.

Li Zhu, Ph.D.

Executive Director & Chief Strategy Officer,
GenScript Biotech Corporation

WHAT TO GARNER
✔ 30+ Media Channel Matrix ✔ 400+ Industry Explicit Delegates
✔ 50+Trending Topics ✔ Meet-and-Greet Partnering Opportunities
✔ Unparalleled Access on 60+ C-Level
    Speakers & KOLs
✔ Deep Insights & Industry Development
    Trends
WHO WILL ATTEND
✔ Biotech & Biopharma ✔ Venture Capital
✔ CROs & CDMOs ✔ Bio Clusters
✔ Academic Research Organizations ✔ IP & Consulting
BREAKOUT TOPICS
GROUP DISCOUNTS AVAILABLE
SPONSORSHIP & EXHIBITION OPPORTUNITIES

Sponsors and exhibitors at the SB&GCT 2021, we value your ROI and always are looking to partner with you closely to stage the top converging activities, so that your financial and resource input are smartly allocated.

PROUD TO PARTNER WITH

Organizers

Genscript Biotech Corporation

Co-Organizers

Jiangsu Biological Technology Association

Jiangsu Drug Research and Development Association

Jiangsu Institute of Immunology

JITRI-Biomedicine and Medical Device Industrial Technology Service Center

Tongxieyi New Drug Elite Club

Supporters

Synthetic Biology Journal

China Biomedical Park Collaboration Alliance (CBPCA)

Nanjing Biomedical Industry Innovation Investment Promotion Association

Chinese Biopharmaceutical Association (CBA)

ReGenesis

Endorsers

China Pharmaceutical Enterprises Association (CPEA)

MEDIA PARTNERS
There is no registration rate for accredited media representatives. Nevertheless, a copy of the official media/press card ID must be submitted.
THE HOTEL & VENUE

At the heart of Gulou District, Shangri-La Nanjing provides a convenient and elegant respite from the bustling city.

Within about 10 minutes’ drive from Nanjing Railway Station and easy access to the Xin Jie Kou shopping center, the hotel offers sweeping views of the city and Xuanwu Lake.

Visit us at http://www.shangri-la.com/nanjing/shangrila/about/.

LOCATION & ACCOMMODATION

Shangri-La Nanjing

  • 329 Zhongyang Road, Gulou District, Nanjing, Jiangsu Province 210037 China
  • (86 25) 8630 8888

We are thrilled to bring the Best Rate Guarantee back to our valued delegates so that their time at the conference period can be largely allocated. Find below the hotel booking system to make your reservation simple and fast at the Shangri-La Nanjing. Happy meeting and staying!

Hotel Reservation

GETTING THERE
Nanjing Railway Station

Approx 10-min ride

Nanjing South Railway Station

Approx 25-min ride

Nanjing Lukou Int'l Airport

Approx 45-min ride

Xuanwu Lake

Approx 15-min within walking distance

About GenScript

GenScript is the leading contract research organization in the world providing gene, peptide, protein, CRISPR, and antibody. Since its foundation in 2002, GenScript has grown exponentially through partnerships with scientists conducting fundamental life science research, translational biomedical research, and early stage pharmaceutical development. The company is recognized as having built a best-in-class capacity and capability for biological research services, encompassing gene synthesis, peptide synthesis, custom antibody and protein engineering, and in vitro and in vivo pharmacology – all with the goal to Make Research Easy. For more information, visit www.genscript.com.

Contact Us

GenScript

MolecularCloud

SGCT

Contact Us: [email protected]

The 4th SynBio & Gene Cell Therapy Industrial Chain Summit